10.2 Cancer Highlights Flashcards
* = also MJ slide
What are 2 origins of cancer?
1) Sporadic: genetic mutation of single somatic cell
2) Inherited (familial)
When cancer occurs as part of a ______________ cancer syndrome, the __________ cancer-causing mutation is inherited through the germline
hereditary; initial
1) The development of cancer is called what?
2) Are most cancers inherited or sporadic?
1) Oncogenesis
2) Sporadic
1) Cancer cells are clonal descendants from how many mutant cells?
2) The cell accumulates many specific mutations over a long period of time; hence, _______ as the primary risk factor for cancer
3) Cancer cells escape control of the cell cycle and begin uncontrolled division and ___________ continue to accumulate
1) one mutant cell
2) age
3) mutations
____________ is a disease process characterized by uncontrolled cellular proliferation leading to the growth of a tumor (neoplasm)
Neoplasia
For a tumor to be cancer, it must also be ______________, which means it is capable of spreading or metastasizing to other locations
malignant
What are 2 primary characteristics of cancer?
invasive and malignant
A process by which cells detach from the primary tumor and move to other sites in the body is called what?
Metastasis
Benign tumors are usually designated by adding what to cell type of origin?
“-oma”
1) What are carcinomas?
2) What is adenocarcinoma?
3) What is SCC?
1) Arise in epithelial tissue*
2) Malignant tumor of glandular cells
3) Malignant tumor of squamous cells
List where each arises:
1) Sarcomas
2) Leukemias
3) Lymphomas
1) Mesenchymal tissue
2) Hematopoietic cells
3) Lymphoid tissue
For benign tumors, describe their:
1) Growth
2) Metastasis
3) External surface
4) Capsule
5) Necrosis
6) Hemorrhage
1) Slow, expansive
2) No
3) Smooth
4) Yes
5) No
6) No
Why does a cancerous mass bleed so much?
Because it can’t create enough blood supply to supply the cells in the middle of the mass, so they die
For malignant tumors, describe their:
1) Growth
2) Metastasis
3) External surface
4) Capsule
5) Necrosis
6) Hemorrhage
1) Fast, invasive
2) Yes
3) Irregular
4) No
5) Yes
6) Yes
For benign tumors, describe their:
1) Architecture
2) Cells
3) Nuclei
4) Mitoses
5) Chromosomes
1) Resembles original tissue
2) Well differentiated
3) Normal size + shape
4) Few
5) Normal
For malignant tumors, describe their:
1) Architecture
2) Cells
3) Nuclei
4) Mitoses
5) Chromosomes
1) Doesn’t resemble tissue of origin
2) Poorly differentiated
3) Pleomorphic
4) Many irregular
5) Aneuploid
List 4 malignant tumors that sound benign
1) Lymphoma
2) Mesothelioma
3) Melanoma
4) Seminoma
List + define 2 non-tumors that sound like tumors
1) Hamartoma: mass of disorganized indigenous tissue
2) Choristoma: heterotopic mass of cells
1) Genes that initiate or maintain cell division are called what?
2) Mutant genes that induce or continue uncontrolled cell proliferation are called what?
1) Proto-oncogenes
2) Oncogenes
ras Proto-Oncogene
1) What does it do when active?
2) What does it do when inactive?
1) Transfers molecular signals from the plasma membrane to the cell nucleus and initiates cell division
2) Cell division is inhibited
1) Genes that mediate programmed cell death are called what?
2) Genes that help maintain the integrity of the genome are called what? Give an example
1) Gatekeeper TSGs
2) Caretaker genes; DNA repair genes
*Tumor suppressor genes:
1) What proteins do these encode?
2) Deletion or inactivation of these products cause cells to do what?
3) _____________ mutations in tumor suppressor genes cause cancer (Two-hit hypothesis)
1) Those
2) Divide continuously
3) Recessive
Cyclin Dependent Kinases AND Cyclin Dependent Kinase Inhibitors (CDKIs)
1) Cyclin Dependent Kinases drive the cell cycle by combining with cyclins to move from one phase to the next
2) CDKIs are inactivated in many cancers (TSGs)
1) Cyclin Dependent Kinases drive the cell cycle by doing what?
2) Cyclins are _____________ in many cancers(oncogenes)
3) While CDKIs are _____________ in many cancers(TSGs)
1) combining with cyclins to move from one phase to the next
2) overexpressed
3) inactivated